U.S. Markets close in 13 mins

Idera Pharmaceuticals, Inc. (IDRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.01000.0000 (0.00%)
As of 3:47PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.82
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.1400
52 Week Low 30.9700
50-Day Moving Average 31.1820
200-Day Moving Average 32.5268

Share Statistics

Avg Vol (3 month) 32.53M
Avg Vol (10 day) 3557.93k
Shares Outstanding 550.03M
Implied Shares Outstanding 6N/A
Float 38.65M
% Held by Insiders 122.62%
% Held by Institutions 119.73%
Shares Short (May 27, 2021) 43.7M
Short Ratio (May 27, 2021) 43.51
Short % of Float (May 27, 2021) 49.40%
Short % of Shares Outstanding (May 27, 2021) 47.40%
Shares Short (prior month Apr 29, 2021) 43.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 29, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Jul 29, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-49.31%
Return on Equity (ttm)-27.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-16.71M
EBITDA -33.52M
Net Income Avi to Common (ttm)-11.23M
Diluted EPS (ttm)-3.5550
Quarterly Earnings Growth (yoy)1,212.70%

Balance Sheet

Total Cash (mrq)44.54M
Total Cash Per Share (mrq)0.89
Total Debt (mrq)1.12M
Total Debt/Equity (mrq)2.65
Current Ratio (mrq)9.41
Book Value Per Share (mrq)0.91

Cash Flow Statement

Operating Cash Flow (ttm)-32.62M
Levered Free Cash Flow (ttm)-46.17M